Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Low plasma haptoglobin is a risk factor for life-threatening childhood severe malarial anemia and not an exclusive consequence of hemolysis.

Abah SE, Burté F, Marquet S, Brown BJ, Akinkunmi F, Oyinloye G, Afolabi NK, Omokhodion S, Lagunju I, Shokunbi WA, Wahlgren M, Dessein H, Argiro L, Dessein AJ, Noyvert B, Hunt L, Elgar G, Sodeinde O, Holder AA, Fernandez-Reyes D.

Sci Rep. 2018 Dec 3;8(1):17527. doi: 10.1038/s41598-018-35944-w.

2.

Liver ultrasound elastography for the evaluation of periportal fibrosis in schistosomiasis mansoni: A cross-sectional study.

Carvalho Santos J, Dória Batista A, Maria Mola Vasconcelos C, Souza Lemos R, Romão de Souza Junior V, Dessein A, Dessein H, Maria Lucena Montenegro S, Pessoa Almeida Lopes E, Lúcia Coutinho Domingues A.

PLoS Negl Trop Dis. 2018 Nov 16;12(11):e0006868. doi: 10.1371/journal.pntd.0006868. eCollection 2018 Nov.

3.

A Functional IL22 Polymorphism (rs2227473) Is Associated with Predisposition to Childhood Cerebral Malaria.

Marquet S, Conte I, Poudiougou B, Argiro L, Dessein H, Couturier C, Burté F, Oumar AA, Brown BJ, Traore A, Afolabi NK, Barry A, Omokhodion S, Shokunbi WA, Sodeinde O, Doumbo O, Fernandez-Reyes D, Dessein AJ.

Sci Rep. 2017 Jan 31;7:41636. doi: 10.1038/srep41636.

4.

Correction: FOXP3+ Regulatory T Cells in Hepatic Fibrosis and Splenomegaly Caused by Schistosoma japonicum: The Spleen May Be a Major Source of Tregs in Subjects with Splenomegaly.

Romano A, Hou X, Sertorio M, Dessein H, Cabantous S, Oliveira P, Li J, Oyegue S, Arnaud V, Luo X, Daujat-Chavanieu M, Mariani O, Sastre X, Dombey AM, He H, Li Y, Dessein A.

PLoS Negl Trop Dis. 2016 Feb 5;10(2):e0004454. doi: 10.1371/journal.pntd.0004454. eCollection 2016 Feb. No abstract available.

5.

FOXP3+ Regulatory T Cells in Hepatic Fibrosis and Splenomegaly Caused by Schistosoma japonicum: The Spleen May Be a Major Source of Tregs in Subjects with Splenomegaly.

Romano A, Hou X, Sertorio M, Dessein H, Cabantous S, Oliveira P, Li J, Oyegue S, Arnaud V, Luo X, Daujat-Chavanieu M, Mariani O, Sastre X, Dombey AM, He H, Li Y, Dessein A.

PLoS Negl Trop Dis. 2016 Jan 5;10(1):e0004306. doi: 10.1371/journal.pntd.0004306. eCollection 2016 Jan. Erratum in: PLoS Negl Trop Dis. 2016 Feb;10(2):e0004454. Chavanieu, Martine [corrected to Daujat-Chavanieu, Martine].

6.

The IL17F and IL17RA Genetic Variants Increase Risk of Cerebral Malaria in Two African Populations.

Marquet S, Conte I, Poudiougou B, Argiro L, Cabantous S, Dessein H, Burté F, Oumar AA, Brown BJ, Traore A, Afolabi NK, Barry A, Omokhodion S, Ndoumbe UE, Shokunbi WA, Sodeinde O, Doumbo O, Fernandez-Reyes D, Dessein AJ.

Infect Immun. 2015 Dec 14;84(2):590-7. doi: 10.1128/IAI.00671-15. Print 2016 Feb.

7.

Potential Use of Interleukin-10 Blockade as a Therapeutic Strategy in Human Cutaneous Leishmaniasis.

Castellano LR, Argiro L, Dessein H, Dessein A, da Silva MV, Correia D, Rodrigues V.

J Immunol Res. 2015;2015:152741. doi: 10.1155/2015/152741. Epub 2015 Oct 1.

8.

Correction: In Vivo MRI Assessment of Hepatic and Splenic Disease in a Murine Model of Schistosmiasis.

Masi B, Perles-Barbacaru TA, Laprie C, Dessein H, Bernard M, Dessein A, Viola A.

PLoS Negl Trop Dis. 2015 Oct 16;9(10):e0004174. doi: 10.1371/journal.pntd.0004174. eCollection 2015 Oct. No abstract available.

9.

In Vivo MRI Assessment of Hepatic and Splenic Disease in a Murine Model of Schistosomiasis [corrected].

Masi B, Perles-Barbacaru TA, Laprie C, Dessein H, Bernard M, Dessein A, Viola A.

PLoS Negl Trop Dis. 2015 Sep 22;9(9):e0004036. doi: 10.1371/journal.pntd.0004036. eCollection 2015 Sep. Erratum in: PLoS Negl Trop Dis. 2015 Oct;9(10):e0004174.

10.

IL2RA genetic variants reduce IL-2-dependent responses and aggravate human cutaneous leishmaniasis.

Oliveira PR, Dessein H, Romano A, Cabantous S, de Brito ME, Santoro F, Pitta MG, Pereira V, Pontes-de-Carvalho LC, Rodrigues V Jr, Rafati S, Argiro L, Dessein AJ.

J Immunol. 2015 Mar 15;194(6):2664-72. doi: 10.4049/jimmunol.1402047. Epub 2015 Feb 11.

11.

IL-22 and IL-22 binding protein (IL-22BP) regulate fibrosis and cirrhosis in hepatitis C virus and schistosome infections.

Sertorio M, Hou X, Carmo RF, Dessein H, Cabantous S, Abdelwahed M, Romano A, Albuquerque F, Vasconcelos L, Carmo T, Li J, Varoquaux A, Arnaud V, Oliveira P, Hamdoun A, He H, Adbelmaboud S, Mergani A, Zhou J, Monis A, Pereira LB, Halfon P, Bourlière M, Parana R, Dos Reis M, Gonnelli D, Moura P, Elwali NE, Argiro L, Li Y, Dessein A.

Hepatology. 2015 Apr;61(4):1321-31. doi: 10.1002/hep.27629. Epub 2015 Mar 10.

PMID:
25476703
12.

Genetic analysis of human predisposition to hepatosplenic disease caused by schistosomes reveals the crucial role of connective tissue growth factor in rapid progression to severe hepatic fibrosis.

Dessein A, Arnaud V, He H, Li J, Dessein H, Hou X, Luo X, Li Y.

Pathol Biol (Paris). 2013 Jan;61(1):3-10. doi: 10.1016/j.patbio.2013.01.005. Epub 2013 Feb 12.

PMID:
23414795
13.

Evaluation of electro-eluted antigens in the serological diagnosis of cutaneous leishmaniasis.

Castellano LR, Gave TC, Lira MA, Dessein H, Dessein A, Correia D, Rodrigues V.

Ann Trop Med Parasitol. 2010 Jun;104(4):347-50. doi: 10.1179/136485910X12743554760063. No abstract available.

PMID:
20659396
14.

Variants of CTGF are associated with hepatic fibrosis in Chinese, Sudanese, and Brazilians infected with schistosomes.

Dessein A, Chevillard C, Arnaud V, Hou X, Hamdoun AA, Dessein H, He H, Abdelmaboud SA, Luo X, Li J, Varoquaux A, Mergani A, Abdelwahed M, Zhou J, Monis A, Pitta MG, Gasmelseed N, Cabantous S, Zhao Y, Prata A, Brandt C, Elwali NE, Argiro L, Li Y.

J Exp Med. 2009 Oct 26;206(11):2321-8. doi: 10.1084/jem.20090383. Epub 2009 Oct 12.

15.

Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-gamma production.

Castellano LR, Filho DC, Argiro L, Dessein H, Prata A, Dessein A, Rodrigues V.

Hum Immunol. 2009 Jun;70(6):383-90. doi: 10.1016/j.humimm.2009.01.007. Epub 2009 Jan 20.

PMID:
19480861
16.

Regulatory role of interleukin-10 and interferon-gamma in severe hepatic central and peripheral fibrosis in humans infected with Schistosoma japonicum.

Arnaud V, Li J, Wang Y, Fu X, Mengzhi S, Luo X, Hou X, Dessein H, Jie Z, Xin-Ling Y, He H, McManus DP, Li Y, Dessein A.

J Infect Dis. 2008 Aug 1;198(3):418-26. doi: 10.1086/588826.

17.

Immunological and genetic evidence for a crucial role of IL-10 in cutaneous lesions in humans infected with Leishmania braziliensis.

Salhi A, Rodrigues V Jr, Santoro F, Dessein H, Romano A, Castellano LR, Sertorio M, Rafati S, Chevillard C, Prata A, Alcaïs A, Argiro L, Dessein A.

J Immunol. 2008 May 1;180(9):6139-48.

18.

Improved technique that allows the performance of large-scale SNP genotyping on DNA immobilized by FTA technology.

He H, Argiro L, Dessein H, Chevillard C.

Infect Genet Evol. 2007 Jan;7(1):128-32. Epub 2006 Aug 22.

PMID:
16920406
19.

Analysis of the 5q31-q33 locus shows an association between IL13-1055C/T IL-13-591A/G polymorphisms and Schistosoma haematobium infections.

Kouriba B, Chevillard C, Bream JH, Argiro L, Dessein H, Arnaud V, Sangare L, Dabo A, Beavogui AH, Arama C, Traoré HA, Doumbo O, Dessein A.

J Immunol. 2005 May 15;174(10):6274-81.

20.

Interleukin-13 in the skin and interferon-gamma in the liver are key players in immune protection in human schistosomiasis.

Dessein A, Kouriba B, Eboumbou C, Dessein H, Argiro L, Marquet S, Elwali NE, Rodrigues V, Li Y, Doumbo O, Chevillard C.

Immunol Rev. 2004 Oct;201:180-90. Review.

PMID:
15361241
21.

Cytokine regulation of periportal fibrosis in humans infected with Schistosoma mansoni: IFN-gamma is associated with protection against fibrosis and TNF-alpha with aggravation of disease.

Henri S, Chevillard C, Mergani A, Paris P, Gaudart J, Camilla C, Dessein H, Montero F, Elwali NE, Saeed OK, Magzoub M, Dessein AJ.

J Immunol. 2002 Jul 15;169(2):929-36.

22.

Induction of a protection against S. mansoni with a MAP containing epitopes of Sm37-GAPDH and Sm10-DLC. Effect of coadsorption with GM-CSF on alum.

Argiro L, Henri S, Dessein H, Kouriba B, Dessein AJ, Bourgois A.

Vaccine. 2000 Apr 3;18(19):2033-8.

PMID:
10706966
23.

Genetics of parasitic infections.

Dessein AJ, Chevillard C, Marquet S, Henri S, Hillaire D, Dessein H.

Drug Metab Dispos. 2001 Apr;29(4 Pt 2):484-8.

PMID:
11259337
24.

Identification of a candidate vaccine peptide on the 37 kDa Schistosoma mansoni GAPDH.

Argiro LL, Kohlstädt SS, Henri SS, Dessein HH, Matabiau VV, Paris PP, Bourgois AA, Dessein AJ.

Vaccine. 2000 Apr 3;18(19):2039-48.

PMID:
10706967
25.

Genetic control of schistosome infections by the SM1 locus of the 5q31-q33 region is linked to differentiation of type 2 helper T lymphocytes.

Rodrigues V Jr, Piper K, Couissinier-Paris P, Bacelar O, Dessein H, Dessein AJ.

Infect Immun. 1999 Sep;67(9):4689-92.

26.
28.

High prevalence of GB-C/hepatitis G virus in a Brazilian population with helminth infection.

Gallian P, Rodrigues V, Cantaloube JF, Dessein H, de Micco P, Dessein AJ, de Lamballerie X.

J Med Virol. 1998 Dec;56(4):310-5.

PMID:
9829634
29.

Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33.

Marquet S, Abel L, Hillaire D, Dessein H, Kalil J, Feingold J, Weissenbach J, Dessein AJ.

Nat Genet. 1996 Oct;14(2):181-4.

PMID:
8841190
30.

Identification of a major T cell immunogen in the anti-schistosome response of adult residents in an area endemic for Schistosoma mansoni.

Couissinier-Paris P, Bourgois A, Dessein H, Bacellar O, Rodrigues V Jr, Kohlstädt S, Buonavista N, Pène J, Dessein AJ.

Eur J Immunol. 1995 Apr;25(4):903-10.

PMID:
7737292
31.

Environmental, genetic and immunological factors in human resistance to Schistosoma mansoni.

Dessein AJ, Couissinier P, Demeure C, Rihet P, Kohlstaedt S, Carneiro-Carvalho D, Ouattara M, Goudot-Crozel V, Dessein H, Bourgois A, et al.

Immunol Invest. 1992 Aug;21(5):423-53. Review.

PMID:
1428019

Supplemental Content

Loading ...
Support Center